Thomson Reuters Big pharma missed out on January’s stock market surge, and analysts across Wall Street think it’s going to get worse. It might get harder for drugmakers to raise prices and keep their sales growing in the manner investors want. Democrats in Congress are starting to investigate the industry, and the Trump administration wants […]